Good to hear. Interested to see progress on debt consolidation and if additional institutional stepped up to absorb debt on company friendly terms as was in 8-k earlier this year.
All signs point to significant expectations in the near future. I would like to hear status of OSA new formulations and additional funding possible in Australia. Also update on NIH tier 3. The bigger catalysts would be a BP deal for epilepsy and/or pain. Either would create a tsunami of investment dollars entering. Hoping this can gravitate to .05-.10 before any such deal and run like other otc pharmas of the past,
Accumulating has been strong several days now absorbing any shares available.. going to be a hot summer!!